Medication info
Lobaduet Tablet 10/10 mg

Lobaduet Tablet 10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Rosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Daewoo Pharmaceutical Co., Ltd.
Appearance
Yellow rectangular film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202004616 · Approved 2020.06.23 · Insurance code 649605870

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Ingredients

Manufacturer
Daewoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • increased LDL cholesterol
  • increased apo B proteins
  • elevated triglycerides
  • increased non-HDL cholesterol
  • increased risk of atherosclerotic vascular diseases due to hypercholesterolemia
View approved original text

This medication is used in conjunction with dietary changes to lower high total cholesterol, LDL cholesterol, apo B proteins, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia, particularly familial and non-familial types, as well as mixed dyslipidemia. In patients at increased risk for atherosclerotic vascular diseases due to hypercholesterolemia, lipid-lowering medications are administered after carefully considering risk factors. This medication is used as an adjunct when dietary and other non-drug treatments, including restrictions on saturated fats and cholesterol, are not effective. Before use, secondary causes of dyslipidemia such as diabetes, hypothyroidism, and chronic renal failure should be checked and treated if necessary. During treatment, monitoring of total cholesterol, LDL, HDL, and triglyceride levels should be conducted regularly, and it is important to examine these levels within 24 hours after an acute coronary event. This medication is effectively used to improve such lipid abnormalities and reduce atherosclerosis risk.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL-cholesterol level, the recommended treatment target, and the patient’s response. Primary hypercholesterolemia The dosage range for this medicine is 10/5mg∼10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL-cholesterol. After starting treatment with this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose should be adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination containing the same amount of each active ingredient) for convenience.

Precautions

This medication carries a risk of muscle problems, so if muscle pain or weakness occurs, it should be reported to a doctor immediately. Special caution is needed in cases of severe infections, hypotension, major surgery or trauma, and metabolic disorders, as the risk of muscle damage and kidney problems increases. Individuals allergic to this medication's active ingredients or components, those with severe liver dysfunction, muscle disorders, specific renal impairment, and women who are pregnant or breastfeeding should avoid taking this medication. Moreover, the risk of muscle damage may increase when taking certain medications together, so patients should consult a doctor or pharmacist if they are taking other drugs. This medication may affect liver function, so those with liver disease or elevated liver enzyme levels must consult a physician before use. During treatment, regular liver function and muscle-related tests should be performed, and any abnormal symptoms should be reported to healthcare professionals immediately. Elderly patients or those with impaired renal function are also at an increased risk for muscle damage, so caution is necessary when taking this medication. This medication may harm the fetus during pregnancy, so it should not be taken if planning to become pregnant or if pregnant, and women of childbearing age should use appropriate contraception while taking it. Safety in children and adolescents has not been established, so its use is not recommended. In case of overdose, as there is no specific antidote, one must immediately go to the hospital for treatment according to symptoms and undergo liver function and muscle enzyme tests. This medication should be stored out of the reach of children and should not be transferred to other containers. Caution should be taken for dizziness that may occur while driving or operating machinery. Any unusual symptoms experienced during the use of this medication should be discussed with a doctor to take appropriate measures.

Side effects

nasopharyngitis, dyspepsia, elevated ALT, edema, myalgia, headache, acute pyelonephritis, dry mouth, elevated liver enzymes, abnormal liver function test, increased serum lactate dehydrogenase, pruritus, upper respiratory tract infection, elevated blood glucose, increased serum CPK, chest discomfort, dizziness, drowsiness, neurodegenerative disorder, orthostatic dizziness, migraine, diabetes, glucose intolerance, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue inflammation, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorder, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, thrombocytopenia, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive decline, forgetfulness, amnesia, memory impairment, confusion, myasthenia gravis, ocular myasthenia, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, weakness, joint pain, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, chest pain, strange sensation, drug intolerance, colorectal polyp, irritable bowel syndrome, esophagitis, polyneuropathy, memory loss, peripheral neuropathy, cough, respiratory difficulty, diarrhea, jaundice, hepatitis, cholelithiasis, cholecystitis, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, cholecystitis, epigastric pain, vomiting, gastritis, xerostomia, epigastric discomfort, belching, gastrointestinal disturbance, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, tremors, anemia, splenomegaly, urticaria, diaphoresis, rash, itching, upper respiratory tract infection, conjunctival hyperemia, renal failure, abnormal liver function, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid contact with air or humidity, and the storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. By doing so, the effectiveness of the medication can be well maintained, and degradation can be prevented.

Appearance and packaging

Appearance

Yellow rectangular film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP x 3], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.